Marshall Wace
RBOT

Marshall Wace’s Vicarious Surgical RBOT Stock Holding History

Marshall Wace’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,202
Closed -$66K – 2594
2023
Q2 		$66K Sell
1,202
-4,777
-80% -$304K ﹤0.01% 2360
2023
Q1 		$407K Buy
+5,979
New +$465K ﹤0.01% 2183
2021
Q3 		– Sell
-37,212
Closed -$11.1M – 3350
2021
Q2 		$11.1M Hold
37,212
– – 0.05% 436
2021
Q1 		$11.1M Buy
37,212
+4,573
+14% +$1.4M 0.05% 403
2020
Q4 		$9.95M Buy
+32,639
New +$9.59M 0.05% 349

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HVCM
Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return

Marshall Wace's RBOT Position: Q3 2023 in Review

Marshall Wace sold out of Vicarious Surgical (RBOT) in Q3 2023, closing a stake of 1,202 shares — an estimated $66K sold.

Marshall Wace first reported a position in RBOT in Q4 2020 and held it in 5 quarters. The position peaked at $11.1M in Q2 2021. 83 funds tracked by Wall St. Rank hold RBOT as of Q3 2023.

  • Marshall Wace reported no remaining Vicarious Surgical position as of Q3 2023 after selling out during the quarter.
  • Marshall Wace sold 1,202 Vicarious Surgical shares in Q3 2023, an estimated $66K.
  • Marshall Wace first reported a position in Vicarious Surgical in Q4 2020 and held it in 5 quarters.
  • Marshall Wace's Vicarious Surgical position peaked at $11.1M in Q2 2021.
  • 83 funds tracked by Wall St. Rank held Vicarious Surgical as of Q3 2023.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.